![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, June 03, 2014 11:50:54 AM
I've been doing a bit of basic modeling and I'm coming up with following...
Assumptions: profit margin of 50%, tax 30%, p/e 18.5, discount rate of 10%.
Otrexup sales: using Ali Yasar sales trajectory numbers
QST: no sales til 2017, at which time they sell $50M (1% of ATRS projected Testosterone market potential of $5B in 2017)
2015
Rev = 125M
Profit = 44M
Shs o/s = 136M
Px = 5.5
2016
Rev = 285M
Profit = 100M
Shs o/s = 138M
Px = 11.1
2017
Rev = 370M
Profit = 130M
Shs o/s = 140M
Px = 12.9
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM